SciELO - Scientific Electronic Library Online

 
vol.38 issue3Epidemiology of neurocysticercosis in BrazilConcomitant high prevalence of Hepatitis C virus antibodies and Hepatitis B virus markers in a small village fo the Amazon Region, Mato Grosso State, Brazil author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista do Instituto de Medicina Tropical de São Paulo

On-line version ISSN 1678-9946

Rev. Inst. Med. trop. S. Paulo vol.38 no.3 São Paulo May/June 1996

https://doi.org/10.1590/S0036-46651996000300009 

THERAPEUTIC TRIAL

 

Norfloxacin monodose use in patients with cholera in Salta, Argentina

 

El uso de monodosis de norfloxacina en pacientes con colera en Salta, Argentina

 

 

Alfredo César SeijoI; Marcos FernandezII; Carolina CamposII; Beatriz Elena CernigoiI; Mabel NoguerasI; Jorge San JuanI; Marcelo Fidel TorresII; Olindo Adrián MartinoI

IHospital de Infecciosas F. J. Muñiz - Municipalidad de la Ciudad de Buenos Aires, ARGENTINA
IIHospital de Salvador Mazza - Província de Salta, AGENTINA

Correspondence to

 

 


SUMMARY

The use ofmonodose (800 mg) per os of Norfloxacin was evaluated in 32 patients with cholera at Salvador Mazza's Hospital, Salta, Argentina. It was considered the celerity in negativization of stool culture (100% of cases: 12 hours post administration), its efficiency along time (24/24 controlled patients were negative at 10th day) and MIC of isolated strains (100% of strains were sensitive: range 0.008 to 0.016 mg/ml). It was included oral administration of sorbitol 70% in peanut oil in order to study patients at 10th day's control. This method could be an alternative one in the study of asymptomatic carrier. Norfloxacin monodose shows good performance in early negativization of stool culture and it was also effective along the whole observation period, suggesting it could prevent carriage.

Keywords: Cholera; Treatment; Norfloxacin; Carriage.


RESUMEN

Se evaluó el uso de monodosis (800 mg) per os de Norfloxacina en 32 pacientes con cólera en el Hospital de Salvador Mazza, Salta, Argentina. Se consideró la rapidez en la negativización del coprocultivo (100% de los casos = 12 horas post administración), su eficacia a través del tiempo (24/24 pacientes controlados fueron negativos al 10° día) y la CIM de las cepas aisladas (100% sensibles, rango 0.008 a 0.016 mg/ml). Para estudiar a los pacientes en el control del 10° día se incluyó la administración oral de sorbitol 70% en aceite de maní. Este método puede ser una alternativa en el estudio del portador asintomático. Norfloxacina en monodosis mostró buen desempeño en la pronta negativización del coprocultivo y fue también efectiva a lo largo de todo el período de observación sugiriendo que puede evitar la portación.


 

 

Full text available only in PDF format.

Texto completo disponible sólo en PDF.

Texto completo disponível apenas em PDF.

 

 

REFERENCES

1. ALAM, A.N.; ALAM, N.H.; AHMED. T. & SACK, D.A. - Randomised double blind trial of single dose doxycycline for treating cholera in adults. Brit. med. J., 300: 1619-1621, 1990.         [ Links ]

2. ANDRIOLE, V.T. - Quinolonas. In: MANDELL, G.L.; DOUGLAS, G.R. & BENNET, J.R., ed. Enfermedades infecciosas. Princípios y práctica. 3. ed. Buenos Aires, Ed. Med. Panamericana, 1991. p. 348-357.         [ Links ]

3. BALOWS, A.; HAUSLER Jr., W.J.; HERRMANN, K.L.; ISEMBERG, H.D. & SHADOMY, H.J., ed. Manual of clinical microbiology. 5 ed. Washington, American Society for Microbiology, 1991. p. 1105-1125.         [ Links ]

4. BENENSON, A.S. - Cholera. In: EVANS, A.S. & BRACHMAN, P.S., ed. Bacterial infections of humans. Epidemiology and control, 2 ed. New York, Plenum Medical Book Company, 1991. p. 207-225.         [ Links ]

5. BATTACHARYA, S.K.; BATTACHARYA, M.K.; DUTTA, D. et al. - Double blind, randomised, controlled clinical trial of Norfloxacin for cholera. Antimicrob. Agents Chemother., 34: 939-940, 1990.         [ Links ]

6. BINZTEIN, N.; EIMAN, M.; RIVAS, M. et al. - Colera en Argentina. In: CONGRESO ARGENTINO DE MICROBIOLOGIA, Buenos Aires, 1995. RESUMO. p. A10.         [ Links ]

7. FARMER III, J.J.; HICKMAN-BRENNER, F.W. & KELLY, T.M. - Vibrio. In: LENNETTE, E.H.; BALLOWS, A.; HAUSLER, W.J. & SHADOMY, H.J. - Manual de microbiologia clinica. 4 ed. Buenos Aires, Ed. Med. Panamericana, 1987. p. 358-382.         [ Links ]

8. GLASS, R.I.; HUGH, M.I.; LEE, J.B. et al. - Plasmid borne multiple drug resistance in Vibrio cholerae serogroup 01 bio-type El Tor: evidence for a point source outbreak in Bangladesh. J. infect. Dis., 147: 204-209, 1983.         [ Links ]

9. GONZALEZ SALDANA, N. & SAL TIGERAL SIMENTAL, P. - Colera conceptos actuales. Mexico, Interamericana Mac Graw-Hill, 1992. p. 119-124.         [ Links ]

10. GREENOUGH III, W.B. - Vibrio cholerae. In: MANDELL, G.L.; DOUGLAS, G.R. & BENNETT, J.E., ed. Enfermedades infecciosas. Princípios y práctica. 3 ed. Buenos Aires, Ed. Med. Panamericana, 1991. p. 1728-1739.         [ Links ]

11. LORIAN, V., ed. - Antibiotics in laboratory medicine. 3 ed. Baltimore, Williams & Wilkins, 1991. p. 665-690.         [ Links ]

12. MAHLU, F.S.; MMARI, P.W. & IJUMBA, J. - Rapid emergence of El Tor V. cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania. Lancet, 1: 345-347, 1979.         [ Links ]

13. PAHO/OMS - Riesgo de transmisión de cólera por los alimentos. Anexo II: metodologia de la administración de alimentos y medicamentos de los EE.UU. (FDA) para la recuperación, identificación y enumeración de las especies patogenicas de Vibrio. Washington, PAHO/OMS, 1991. p. 3-34.         [ Links ]

14. RABBANI, G.H.; ISLAM, M.R.; BUTLER, T.; SHAHRIER, M. & ALAM, K. - Single dose treatment of cholera with furazolidone or tetracycline in a double-blind randomised trial. Antimicrob. Agents Chemother., 33: 1447-1450, 1989.         [ Links ]

15. ROSSI, A.; GALAS, M. & BINZTEIN, N. - Unusual multiresistant Vibrio cholerae 01 El Tor in Argentine. Lancet, 342: 1172-1173, 1993.         [ Links ]

16. TABTIENG, R.; WATTANASRI, S.; ECHEVERRIA, P. et al. - An epidemic of V. cholerae El Tor Inaba resistant to several antibiotics with a conjugative group C plasmid coding for type II dihydrofolate reductase in Thailand. Amer. J. trop. Med. Hyg., 41: 680-686, 1989.         [ Links ]

17. THRELFALL, E.J.; SAID, B.; ROWE, B. & DA VALOS PEREZ, A. - Emergence of multiple drug resistance in V. cholerae 01 El Tor from Ecuador. Lancet, 342: 1173, 1993.         [ Links ]

 

 

Correspondence to:
Dr. Alfredo C. Seijo
Hospital F.J. Muñiz
Uspallata 2272 - (1282)
Buenos Aires, ARGENTINA

Recebido para publicação em 05/01/1996
Aceito para publicação em 05/06/1996

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License